Abnormalities in mineral metabolism worsen with progression of chronic kidney disease (CKD) and are associated with an increased risk of end-stage renal disease (ESRD) among African American individuals with hypertensive kidney disease, according to new research. Using data from the AASK study, Scialla et al. found that serum levels of FGF23, PTH and phosphate increased during 4 years of follow-up; the greatest increases were seen in participants with the fastest rates of decline in glomerular filtration rate (GFR). Higher baseline levels of these mineral metabolites were each associated with increased risk of ESRD or death independent of GFR.
ORIGINAL RESEARCH PAPER
Scialla, J. J. et al. Mineral metabolites and CKD progression in African Americans. J. Am. Soc. Nephrol. doi:10.1681/ASN.2012070713
Rights and permissions
About this article
Cite this article
Mineral metabolite abnormalities and CKD progression. Nat Rev Nephrol 9, 65 (2013). https://doi.org/10.1038/nrneph.2012.274
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.274